🧬 Bispecific antibodies are reshaping R/R multiple myeloma care. Explore the latest clinical trial data, tackle real-world barriers to implementation, and learn how to personalize therapy while managing AEs. 🩸 Advance your approach—join us! mdsc.pe/3Sy3Apg #ASH26

🫘 Managing hyperphosphatemia in CKD goes beyond phosphate control! Explore comorbidity risks, novel phosphate-lowering therapies, and team-based strategies to improve patient care. 💡 Expand your expertise—learn more! mdsc.pe/4ibH2ni

🩺 Bring fresh ideas back to your family medicine practice! 🔎 Discover 9 live MedscapeLIVE! CME symposia at #AAFPFMX2026, featuring expert-led discussions, patient journeys, live clinics, interactive formats & more. ⏰ Don’t wait—reserve your seat today! mdsc.pe/3TIyP1z

🩸 At #ASH26, explore the latest data on bispecific antibodies for R/R DLBCL, including when transplant or CAR T may not be suitable. Gain practical insights to inform treatment decisions. Register today: mdsc.pe/4yldhag

🔬 Go beyond the pain signal. Dive into the physiology behind acute pain transmission and explore the 🎯 evidence supporting non-opioid analgesics for acute pain management. 🩺 Turn the latest science into smarter pain care—save your spot! mdsc.pe/4cuozAk

🔬 Could factor XIa inhibitors change the secondary stroke prevention landscape? 🧠Examine the latest clinical evidence, who’s being studied in phase 3 trials & what emerging data reveal about benefits and risks. 🛡️ Bring tomorrow’s evidence into focus 👉 mdsc.pe/461BplZ

⚖️ Combination or single-agent? Short- or longer-acting? Dive into the latest evidence on OTC nonopioid analgesics 🧠 learn to navigate safety, comorbidities & patient preferences in pain care. 💊 Turn evidence into better pain management! mdsc.pe/3SmNkHW #AAFPFMX

🧩 CKM syndrome doesn’t fit neatly into one specialty. Recognize overlapping clinical markers, explore the evolving role of nsMRAs, + 🫀translate the latest evidence into primary care. 🫘 Connect the dots, coordinate care & reduce risk👇 mdsc.pe/3SKengb #AAFPFMX

🥜 When is it time to rethink the plan for multiple food allergies? Recognize when patients may benefit from treatment escalation, individualize care, and strengthen shared decisions with patients and caregivers. 💬 Expand your approach—register today! mdsc.pe/45P9ndj

🫀 When CV risk isn’t clear, imaging can sharpen the picture. Explore how CAC scoring & carotid ultrasound can refine risk, guide personalized prevention, 🎯 support patient conversations. 📸 Bring greater clarity to CV prevention—register today! mdsc.pe/4x52SOM #AAFPFMX

🎓 Learn from leaders shaping modern psychiatry. From complex cases to evolving therapies—including psychedelics—gain insights you can apply immediately 👉 Access expert insight: mdsc.pe/41GEJRd #PsychPharm26

🔬 Novel ADCs are advancing breast cancer care! 🧬 @JavierCortesMD, @RebeccaDSing & @stolaney1 highlight emerging trial data, biomarker-driven strategies, and evolving treatment approaches across breast cancer subtypes. 🎯 mdsc.pe/3TKIKni #ESMO

🔎 Look beyond symptom control in AD. Compare targeted systemic and biologic therapies, identify appropriate candidates 📈 for escalation & discover how a treat-to-target approach can shape treatment decisions. 🌟 Elevate your approach—join us! mdsc.pe/4xEBCqy

⚡ Diabetes technology is changing how we manage care. Explore the evidence behind monitoring devices, discover practical ways to bring them into everyday practice & 📊strengthen team-based diabetes management.🤝 Make every reading count! mdsc.pe/4gEjnLj #AAFPFMX

🚨 MASH can progress before the warning signs are obvious. Explore the urgent need for earlier intervention, review data on novel therapies, and learn how noninvasive tests can help identify and manage at-risk patients. 🔬 Stay ahead—register today! mdsc.pe/4cbI28K #AASLD

🚦PAH can be easy to miss—until it isn’t.Sharpen your ability to recognize early signs and METH-PAH risk, use echo and clinical tools for risk stratification, and navigate treatment 💊 titration and tolerability. 🫁 Act earlier—register today! mdsc.pe/3UfsbzT

🌙 NT1 care is entering a new era. Compare orexin receptor agonists with wake-promoting agents, unpack the latest clinical data, and strengthen your ability to recognize and diagnose narcolepsy type 1. 🧬💡 Wake up to what’s next—reserve your spot! mdsc.pe/45QnuiD

📊 Ready to advance mCRPC care? Examine emerging radiopharmaceutical combination data, the role of bone-protecting agents, and practical strategies for coordinated, evidence-based treatment delivery. 🎯 mdsc.pe/4xIHv6p

🔍 Could PFIC or ALGS be hiding in your adult patients? Strengthen recognition & diagnosis, navigate the appropriate use of targeted therapies 🧬 & discover how interprofessional care can address their multisystem impact. 🤝 Be ready for these cases— mdsc.pe/4h8ewDH

🧬 Discover the latest advances in platinum-resistant ovarian cancer from novel ADCs and emerging combination therapies to biomarker-driven treatment decisions. 👉 mdsc.pe/3TNOOvi #OvarianCancer #Oncology #PROC #ESMO